DYADIC INTERNATIONAL INC cotiza a 0.42 USD y tiene una capitalización bursátil de $17M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes …
| Periodo | 2026-08 | 2026-05 | 2026-03 | 2025-11 |
|---|---|---|---|---|
| Real | $-0.06 | $-0.05 | $-0.06 | $-0.06 |
| Estimado | $-0.04 | $-0.04 | $-0.04 | $-0.04 |
| Sorpresa | -50.0% | -25.0% | -50.0% | -50.0% |
| Métrica | DYAI | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 24.9% | 57.0% | -32.1% |
| Operating Margin | -232.8% | -38.6% | -194.1% |
| Net Margin | -238.3% | -33.6% | -204.8% |
| FCF Margin | — | -13.9% | — |
| ROE | -597.6% | -40.4% | -557.2% |
| ROA | -74.0% | -32.0% | -42.0% |
| Current Ratio | 2.68 | 2.84 | -0.16 |
| Debt / Equity | — | 0.28 | — |